Friday, November 1, 2024
spot_img

Change in Vaisala Corporation’s number of series A and K shares

Vaisala Corporation
Stock exchange release
November 1, 2024, at 10:20 a.m. EET

Change in Vaisala Corporation’s number of series A and K shares

Vaisala Corporation’s Board of Directors decided in its meeting on October 23, 2024, that 14,823 series K shares will be converted into series A shares. This conversion was registered into the Trade Register today, on November 1, 2024. Consequently, Vaisala has 36,436,728 shares, of which 3,626,853 are series K shares and 32,809,875 are series A shares. Total votes attached to all shares is 105,346,935. Vaisala holds a total of 152,149 company’s series A shares, which represent 0.46% of series A shares and 0.42% of all shares.

More information
Paula Liimatta
+358 9 8949 2020, [email protected]

Distribution
Nasdaq Helsinki
Key media
vaisala.com

Vaisala is a global leader in measurement instruments and intelligence for climate action. We equip our customers with devices and data to improve resource efficiency, drive energy transition, and care for the safety and well-being of people and societies worldwide. With almost 90 years of innovation and expertise, we employ a team of over 2,300 experts committed to taking every measure for the planet. Vaisala series A shares are listed on the Nasdaq Helsinki stock exchange. vaisala.com

Powered by SlickText.com

Hot this week

Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial

DENVER, Nov. 01, 2024 (GLOBE NEWSWIRE) --...

Founder Group Limited Announces USD$3.8 million New Solar EPCC Photovoltaic Contract

SELANGOR, Malaysia, Nov. 01, 2024 (GLOBE NEWSWIRE)...

Fobi AI Provides Corporate Update

VANCOUVER, BC, Nov. 01, 2024 (GLOBE NEWSWIRE)...

Galecto Reports Third Quarter 2024 Financial Results

-  Completed strategic review to focus on oncology and...

Topics

Fobi AI Provides Corporate Update

VANCOUVER, BC, Nov. 01, 2024 (GLOBE NEWSWIRE)...

Galecto Reports Third Quarter 2024 Financial Results

-  Completed strategic review to focus on oncology and...

Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control

FemBloc issued patent provides additional coverage for Femasys’ therapeutic...

Share buy-back programme at SP Group A/S

On 26 August 2024 SP Group initiated a share...
spot_img

Related Articles

Popular Categories

spot_img